Algenis

Algenis is an known in the R&D of natural sodium channel blocker molecules derived from microalgae.

Algenis is an known in the R&D of natural sodium channel blocker molecules derived from microalgae. The company aims to be a leader in the production, formulation, and clinical development of bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. Algenis' strategy is to commercialize our products through licensing, co-development, or direct sales options. Algenis' first therapeutic indication is for the treatment and healing of anal fissures.